SOHO Global Health

sohoglobalhealth.com

SOHO Global Health has expanded the business from manufacturing and distribution of pharmaceutical products to fine quality herbal cures, proprietary medicines and health foods under various brand names. We have grown into a global manufacturer and our presence is seen in five countries regionally and globally.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

VIEWS AND ANALYSIS, PHARMA TECH

NOVAVAX ANNOUNCES PRICING OF $150 MILLION OFFERING OF CONVERTIBLE SENIOR NOTES

Novavax, Inc. | December 16, 2022

news image

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an offering of $150 million aggregate principal amount of its 5.00% convertible senior notes due 2027. The notes are being offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In connection with the offering of the notes, No...

Read More

ARGENX LIGHTS UP BRIDGES, TEASES DOCUMENTARY IN MYASTHENIA GRAVIS AWARENESS PUSH

Fiercepharma | June 08, 2020

news image

Argenx is launching its first awareness efforts for autoimmune disease myasthenia gravis. The campaign began recently with a virtual conference, light-up nights around the country, a patient website debut and the promise of an upcoming documentary. The kickoff event on June 1, which was also the first day of MG Awareness Month, was a virtual meeting of physician and patient speakers along with the first MG Illuminate night that lit up the Zakim Bridge in Boston in the color teal. Throughout the ...

Read More

DIGITAL & DOCUMENTATION TRANSFORMATION KEY TO PHARMA, MANUFACTURING AND ENERGY SURVIVAL AMIDST COVID-19

Sdcexec | April 28, 2020

news image

Last week, the U.S. energy sector faced a severe blow as the value of oil to be delivered in May dropped to a staggering -$37.60 per barrel—the first negative close in history. Pharma and manufacturing industries are facing similar wake-up calls for a future riddled with uncertainty. But the key to maintaining operations during and after the coronavirus crisis revolves around digital transformation and document management for processes, analytics, and an agile workforce, according to Brian...

Read More

Business Insights

C-PATH AND REPLICA ANALYTICS COLLABORATION AIMS TO ACCELERATE RARE DISEASE RESEARCH

Replica Analytics | June 30, 2022

news image

Critical Path Institute and Replica Analytics, an Aetion company, announced a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together...

Read More
news image

VIEWS AND ANALYSIS, PHARMA TECH

NOVAVAX ANNOUNCES PRICING OF $150 MILLION OFFERING OF CONVERTIBLE SENIOR NOTES

Novavax, Inc. | December 16, 2022

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an offering of $150 million aggregate principal amount of its 5.00% convertible senior notes due 2027. The notes are being offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In connection with the offering of the notes, No...

Read More
news image

ARGENX LIGHTS UP BRIDGES, TEASES DOCUMENTARY IN MYASTHENIA GRAVIS AWARENESS PUSH

Fiercepharma | June 08, 2020

Argenx is launching its first awareness efforts for autoimmune disease myasthenia gravis. The campaign began recently with a virtual conference, light-up nights around the country, a patient website debut and the promise of an upcoming documentary. The kickoff event on June 1, which was also the first day of MG Awareness Month, was a virtual meeting of physician and patient speakers along with the first MG Illuminate night that lit up the Zakim Bridge in Boston in the color teal. Throughout the ...

Read More
news image

DIGITAL & DOCUMENTATION TRANSFORMATION KEY TO PHARMA, MANUFACTURING AND ENERGY SURVIVAL AMIDST COVID-19

Sdcexec | April 28, 2020

Last week, the U.S. energy sector faced a severe blow as the value of oil to be delivered in May dropped to a staggering -$37.60 per barrel—the first negative close in history. Pharma and manufacturing industries are facing similar wake-up calls for a future riddled with uncertainty. But the key to maintaining operations during and after the coronavirus crisis revolves around digital transformation and document management for processes, analytics, and an agile workforce, according to Brian...

Read More
news image

Business Insights

C-PATH AND REPLICA ANALYTICS COLLABORATION AIMS TO ACCELERATE RARE DISEASE RESEARCH

Replica Analytics | June 30, 2022

Critical Path Institute and Replica Analytics, an Aetion company, announced a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us